In fungal lung infections, when is biopsy for treatment decisions considered?

In fungal lung infections, when is biopsy for treatment decisions considered?

• A. When biopsy is needed for treatment decisions or cancer cannot be excluded
• B. Only after antifungal failure
• C. No surgery ever
• D. For cosmetic reasons

Answer: (A)

Tissue diagnosis is essential when lung lesions could be fungal disease or cancer, and the treatment plan depends on knowing the exact cause. A biopsy provides histopathology and cultures that confirm a fungal infection, identify the specific organism, and determine whether the disease is invasive or a benign colonization. This information directly guides which antifungal regimen to use, how long to treat, and whether additional surgical intervention is needed, and it helps rule out malignancy that would require oncologic management. Because imaging alone cannot reliably distinguish fungal infection from cancer, a biopsy is considered when it will influence treatment decisions or when cancer cannot be excluded. Waiting until antifungal therapy fails or aiming for cosmetic reasons does not align with the clinical need for definitive diagnosis.

Tissue diagnosis is essential when lung lesions could be fungal disease or cancer, and the treatment plan depends on knowing the exact cause. A biopsy provides histopathology and cultures that confirm a fungal infection, identify the specific organism, and determine whether the disease is invasive or a benign colonization. This information directly guides which antifungal regimen to use, how long to treat, and whether additional surgical intervention is needed, and it helps rule out malignancy that would require oncologic management. Because imaging alone cannot reliably distinguish fungal infection from cancer, a biopsy is considered when it will influence treatment decisions or when cancer cannot be excluded. Waiting until antifungal therapy fails or aiming for cosmetic reasons does not align with the clinical need for definitive diagnosis.